InsiderClue
Stocks · Health care · Pharmaceutical Preparations

TG THERAPEUTICS, INC.

TGTX Clue Score71
United States Fiscal year ends December CIK 0001001316
$55.37 +3.81% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $55.37 +72.92% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue0.2Operating income−79.0Net income−78.3Fiscal year 2017Revenue0.2 +0.0%Operating income−118.7Net income−118.5Fiscal year 2018Revenue0.2 +0.0%Operating income−174.4Net income−173.5Fiscal year 2019Revenue0.2 +0.0%Operating income−169.1Net income−172.9Fiscal year 2020Revenue0.2 +0.0%Operating income−273.6Net income−279.4EPS, diluted−2.42Fiscal year 2021Revenue6.7 +4,300.7%Operating income−344.8Net income−348.1EPS, diluted−2.63Fiscal year 2022Revenue2.8 −58.4%Operating income−218.3Net income−223.8EPS, diluted−1.65Fiscal year 2023Revenue233.7 +8,290.0%Operating income20.6Net income12.7EPS, diluted0.09Fiscal year 2024Revenue329.0 +40.8%Operating income41.9Net income23.4 +84.5%EPS, diluted0.15 +66.7%Fiscal year 2025Revenue616.3 +87.3%Operating income123.3Net income447.2 +1,812.4%EPS, diluted2.77 +1,746.7%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.2 0.2 0.2 0.2 0.2 6.7 2.8 233.7 329.0 616.3
Growth +0.0% +0.0% +0.0% +0.0% +4,300.7% −58.4% +8,290.0% +40.8% +87.3%
Operating income −79.0 −118.7 −174.4 −169.1 −273.6 −344.8 −218.3 20.6 41.9 123.3
Net income −78.3 −118.5 −173.5 −172.9 −279.4 −348.1 −223.8 12.7 23.4 447.2
Growth +84.5% +1,812.4%
EPS, diluted n/a n/a n/a n/a −2.42 −2.63 −1.65 0.09 0.15 2.77
Growth +66.7% +1,746.7%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−51,953.3%Net margin−51,482.2%Free cash flow margin−40,744.1%Fiscal year 2017Operating margin−78,100.0%Net margin−77,944.7%Free cash flow margin−61,685.5%Fiscal year 2018Operating margin−114,736.8%Net margin−114,132.9%Free cash flow margin−84,878.3%Fiscal year 2019Operating margin−111,220.4%Net margin−113,730.9%Free cash flow margin−87,458.6%Fiscal year 2020Operating margin−179,996.1%Net margin−183,803.3%Free cash flow margin−141,357.9%Fiscal year 2021Operating margin−5,154.3%Net margin−5,204.1%Free cash flow margin−4,425.7%Fiscal year 2022Operating margin−7,839.0%Net margin−8,036.3%Free cash flow margin−6,326.2%Fiscal year 2023Operating margin8.8%Net margin5.4%Free cash flow margin−13.4%Fiscal year 2024Operating margin12.7%Net margin7.1%Free cash flow margin−12.3%Fiscal year 2025Operating margin20.0%Net margin72.6%Free cash flow margin−4.1%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −51,953.3% −78,100.0% −114,736.8% −111,220.4% −179,996.1% −5,154.3% −7,839.0% 8.8% 12.7% 20.0%
Net margin −51,482.2% −77,944.7% −114,132.9% −113,730.9% −183,803.3% −5,204.1% −8,036.3% 5.4% 7.1% 72.6%
Free cash flow margin −40,744.1% −61,685.5% −84,878.3% −87,458.6% −141,357.9% −4,425.7% −6,326.2% −13.4% −12.3% −4.1%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−61.6Capital expenditure−0.3Free cash flow−61.9Fiscal year 2017Operating cash flow−93.8Capital expenditure−0.0Free cash flow−93.8Fiscal year 2018Operating cash flow−128.9Capital expenditure−0.1Free cash flow−129.0Fiscal year 2019Operating cash flow−132.8Capital expenditure−0.1Free cash flow−132.9Fiscal year 2020Operating cash flow−214.5Capital expenditure−0.4Free cash flow−214.9Fiscal year 2021Operating cash flow−295.6Capital expenditure−0.4Free cash flow−296.0Fiscal year 2022Operating cash flow−176.2Capital expenditure−0.0Free cash flow−176.2Fiscal year 2023Operating cash flow−31.4Capital expenditure0.0Free cash flow−31.4Fiscal year 2024Operating cash flow−40.5Capital expenditure−0.0Free cash flow−40.6Fiscal year 2025Operating cash flow−24.8Capital expenditure−0.2Free cash flow−25.0
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −61.6 −93.8 −128.9 −132.8 −214.5 −295.6 −176.2 −31.4 −40.5 −24.8
Capital expenditure −0.3 −0.0 −0.1 −0.1 −0.4 −0.4 −0.0 0.0 −0.0 −0.2
Free cash flow −61.9 −93.8 −129.0 −132.9 −214.9 −296.0 −176.2 −31.4 −40.6 −25.0
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash25.0Shareholders’ equity35.9Fiscal year 2017Cash56.7Shareholders’ equity67.0Fiscal year 2018Cash42.0Total debt0.0Net cash (debt)42.0Shareholders’ equity24.0Debt to equity0.00Fiscal year 2019Cash112.6Total debt29.0Net cash (debt)83.7Shareholders’ equity38.6Debt to equity0.75Fiscal year 2020Cash553.4Total debt29.9Net cash (debt)523.5Shareholders’ equity519.4Debt to equity0.06Fiscal year 2021Cash298.9Total debt67.8Net cash (debt)231.1Shareholders’ equity237.2Debt to equity0.29Fiscal year 2022Cash102.3Total debt71.1Net cash (debt)31.2Shareholders’ equity58.6Debt to equity1.21Fiscal year 2023Cash92.9Total debt100.1Net cash (debt)−7.2Shareholders’ equity160.5Debt to equity0.62Fiscal year 2024Cash179.9Total debt244.4Net cash (debt)−64.5Shareholders’ equity222.4Debt to equity1.10Fiscal year 2025Cash79.1Total debt245.6Net cash (debt)−166.5Shareholders’ equity648.0Debt to equity0.38
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 25.0 56.7 42.0 112.6 553.4 298.9 102.3 92.9 179.9 79.1
Total debt n/a n/a 0.0 29.0 29.9 67.8 71.1 100.1 244.4 245.6
Net cash (debt) n/a n/a 42.0 83.7 523.5 231.1 31.2 −7.2 −64.5 −166.5
Shareholders’ equity 35.9 67.0 24.0 38.6 519.4 237.2 58.6 160.5 222.4 648.0
Debt to equity n/a n/a 0.00 0.75 0.06 0.29 1.21 0.62 1.10 0.38

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Balance sheet

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Assets
25.0 56.7 42.0 112.6 553.4 298.9 102.3 92.9 179.9 79.1
n/a n/a n/a n/a n/a n/a 0.0 51.1 129.2 305.6
n/a n/a n/a n/a n/a n/a 0.0 39.8 110.5 125.6
0.3 0.2 0.3 0.3 0.5 0.6 0.3 0.1 n/a n/a
0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 n/a n/a
54.8 97.4 83.6 163.0 625.6 379.6 193.6 329.6 577.7 1,063.3
Growth +77.8% −14.1% +95.0% +283.8% −39.3% −49.0% +70.3% +75.3% +84.1%
Liabilities
n/a n/a n/a 0.0 22.2 1.0 0.0 n/a n/a n/a
n/a n/a 0.0 29.0 7.7 66.8 71.1 100.1 244.4 245.6
calc n/a n/a 0.0 29.0 29.9 67.8 71.1 100.1 244.4 245.6
18.9 30.4 59.6 124.4 106.3 142.5 135.0 169.1 355.3 415.2
Equity
−236.4 −354.9 −528.3 −701.2 −980.6 −1,328.7 −1,527.0 −1,552.6 −1,529.2 −1,082.0
35.9 67.0 24.0 38.6 519.4 237.2 58.6 160.5 222.4 648.0
Growth +86.8% −64.1% +60.7% +1,244.9% −54.3% −75.3% +174.0% +38.5% +191.4%
Per share and net cash
calc n/a n/a 42.0 83.7 523.5 231.1 31.2 −7.2 −64.5 −166.5
56.8 73.1 83.9 109.4 140.6 143.3 146.4 151.4 155.8 155.3
calc 0.63 0.92 0.29 0.35 3.69 1.66 0.40 1.06 1.43 4.17

Lines marked calc are worked out here from filed figures; point at one for how.